key: cord-0863934-2rwfbaps
authors: Yamazaki, W.; Matsumura, Y.; Thongchankaew-Seo, U.; Yamazaki, Y.; Nagao, M.
title: Development of a highly sensitive point-of-care test to detect SARS-CoV-2 from saliva combining a simple RNA extraction method with colorimetric reverse transcription loop-mediated isothermal amplification detection
date: 2020-11-12
journal: nan
DOI: 10.1101/2020.11.08.20227702
sha: cdbc5645ec293e2c66977b3d73abff5f8f11913b
doc_id: 863934
cord_uid: 2rwfbaps

To diagnose COVID-19 patients in the field, a sensitive point-of-care test using saliva was developed. Using a heat block without centrifuge, the test took 45 minutes. Naked eye judgement with color change dye outperformed the reference standard, with a diagnostic sensitivity of 82.6% (19/23) and diagnostic specificity of 100% (21/21).

With progressing globalization, the worldwide spread of infectious diseases has accelerated. The new coronavirus infection (COVID-19) is a major public health concern (WHO, 2020). With the high burden and risk for infection among patients and healthcare workers, the advent of reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) testing as an alternative to nasopharyngeal swab sampling for diagnosing COVID-19 has increased the use of saliva (Azzi et al., The combined use of the direct-to-test addition by heating and RT-qPCR using a nasopharyngeal swab sample has proven successful due to reduced inhibitory All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ; https://doi.org/10.1101/2020.11.08.20227702 doi: medRxiv preprint effects (Esbin et. al, 2020) . However, the saliva sample must undergo high-speed centrifugation at 20,000 g for 5-30 min following purification with a commercial RNA extraction kit to remove potential inhibitors (Azzi et al. This tedious RNA extraction process, which requires a well-equipped laboratory, is a major hurdle for performing sensitive point-of-care testing (POCT) for COVID-19 using saliva.

Reverse transcription loop-mediated isothermal amplification (RT-LAMP) is an attractive option for achieving more-sensitive POCT than an immunochromatographic assay because of its broader utility and portable real-time detector with an in-house buttery or combination use with a cost-effective heat block and colorimetric reagent Here, we developed a simple method for extracting RNA from saliva samples using semi-alkaline proteinase (SAP), a sputum homogenizer for tuberculosis examinations, and a subsequent simple heating step, with no need for centrifugation or RNA extraction. Further, we newly developed a triplex RT-LAMP approach using colorimetric readout in a heat block for the naked eye judgement. We preliminarily evaluated the POCT performance with 44 clinical saliva samples. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ; https://doi.org/10.1101/2020.11.08.20227702 doi: medRxiv preprint

We used Primer Explorer V5 (primerexplorer.jp/lampv5e/index.html) to design three primer sets targeting the ORF 1ab, S, and ORF 7a regions to simultaneously detect SARS-CoV-2 with high sensitivity and robustness. To identify highly conserved nucleotide sequences with low similarity to SARS-CoV-1 sequences, we performed multiple sequence alignment using Clustal Omega preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ; Basel, Switzerland) according to the protocol recommended by the National Institute of Infectious Diseases, Japan (Shirato et al., 2020). Ten-fold serial dilutions (5 to 5×10 6 copies/reaction) of the synthesized RNA containing the target sequence (Shirato et al., 2020) were used to calculate the viral loads in clinical samples.

In parallel, for POCT, the remaining SS mix was heated at 95 °C for 5 min, and then the tube was centrifuged using a dry-cell battery-powered tabletop centrifuge for approximately 5 sec or swung manually to remove the aqueous droplet on the tube lid.

Using 50 µl of RT-LAMP reaction mixtures (including 10 μ l of template), the RT-LAMP reaction was monitored using a LightCycler 480 System II (Roche) at 63 °C for 25 min.

Subsequent procedures were completed without interruption, or else the SS mix was stored at -80 °C until used. The limit of detection (LOD) of triplex RT-LAMP was defined as the lowest concentration at which 95% of positive samples were detected using a 2-fold series of phosphate-buffered saline dilutions in maximum 20 replicates of 50,000, 25,000, 12,500, and 10,000 copies/ml of heat-inactivated SARS-CoV-2 (ATCC VR-1986HK; American Type Culture Collection, Manassas, VA, USA) ( Table   2 ). The dilutions were heated at 95 °C for 5 min. After removal of the aqueous droplet on the tube lid, 10 μ l of the template was applied to 50 µl of RT-LAMP reaction mixture, as described above.

Compared to reference standard, the diagnostic sensitivity and specificity were 82.6% (19/23; 95% confidence interval [CI], 61.2%-95.1%) and 100% (21/21, 95% CI, 83.8%-100%) for the new POCT, which took 45 min from starting crude RNA extraction to endpoint readout with the naked eye (Table 1, Figure 1 ). As shown in Table 1 , 18 clinical samples exceeding 380 copies/reaction (>33,000 copies/ml of All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ; https://doi.org/10.1101/2020.11.08.20227702 doi: medRxiv preprint saliva) by reference standard measurement were positive on POCT between 9:02 and 16:12 for amplification. Three samples showing low copy numbers at 170-230 copies/reaction (15,000-20,000 copies/ml of saliva) on RT-qPCR were only 1 positive at 23:32 and 2 false negatives in POCT, which were interpreted as borderline samples near the LOD of POCT. Another 2 samples showing lower copy numbers at 13-86 copies/reaction (1,100-7,400 copies/ml of saliva) were both false negatives, possibly due to below the detection power of the POCT. The result obtained by the LOD determination was the value of 250 copies/reaction (25,000 copies/ml) ( Table 2) .

Our newly developed POCT approach achieved simple RNA extraction and constant RT-LAMP without the need for high-speed centrifugation, nucleic acid extraction kits, or qPCR equipment. This POCT does not require expensive equipment and performs comparably to an existing reference standard. This POCT can thus be used for drive-through testing and simple inspection stations in a field setting, helping reduce the risk of infection by simplifying and accelerating testing for COVID-19. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ; https://doi.org/10.1101/2020.11.08.20227702 doi: medRxiv preprint wrote the manuscript, and all authors read and approved the final manuscript.

The Ethics Committee of Kyoto University Graduate School and the Faculty of Medicine approved this study (R2379) and waived the need for obtaining informed consent from each patient.

Wataru Yamazaki is a veterinarian and microbiologist. He specializes in food microbiology and infectious diseases for both humans and animals and has been particularly involved in the development of LAMP and other molecular-based testing methods as well as POCT for fieldwork for over 15 years. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ; preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. RT-qPCR, Reverse transcription quantitative real-time polymerase chain reaction All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ; https://doi.org/10.1101/2020.11.08.20227702 doi: medRxiv preprint LOD, Limit of detection.

RT-LAMP, Reverse transcription loop-mediated isothermal amplification detection.

SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2.

All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ; https://doi.org/10.1101/2020.11.08.20227702 doi: medRxiv preprint preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

Saliva is a reliable tool to detect SARS-CoV-2

Loop-Mediated Isothermal Amplification (LAMP): A Rapid, Sensitive, Specific, and Cost-Effective Point-of-Care Test for Coronaviruses in the Context of COVID-19 Pandemic

Variplex™ test system fails to reliably detect SARS-CoV-2 directly from respiratory samples without RNA extraction

Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detection

Direct blood dry LAMP: a rapid, stable, and easy diagnostic tool for Human African Trypanosomiasis

All rights reserved. No reuse allowed without permission

the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted

Clinical evaluation of self-collected saliva by RT-qPCR, direct RT-qPCR, RT-LAMP, and a rapid antigen test to diagnose COVID-19

Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Development of Genetic Diagnostic Methods for Novel Coronavirus

All rights reserved

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted

This research was supported by AMED under Grant Number JP20he0622031.

The authors declare that they have no conflicts of interest. All authors contributed to the study conception and design. WY, UTS, and YY developed RT-LAMP. YM and MN conducted POCT with clinical samples. WY and MN organized the study. WY and YM

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this this version posted November 12, 2020. ; All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this this version posted November 12, 2020. ; https://doi.org/10.1101/2020.11.08.20227702 doi: medRxiv preprint S- Table 3 

All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this this version posted November 12, 2020. ; https://doi.org/10.1101/2020.11.08.20227702 doi: medRxiv preprint